7-dehydrocholesterol reductase
Showing 1 - 25 of >10,000
Multiple Sclerosis, Relapsing-Remitting, Adult ALL, Vitamin D3 Deficiency Trial (25(OH)D3, vitamin D3)
Not yet recruiting
- Multiple Sclerosis, Relapsing-Remitting
- +2 more
- 25(OH)D3
- vitamin D3
- (no location specified)
Apr 16, 2022
Biochemical and Phenotypical Aspects of Smith-Lemli-Opitz
Recruiting
- Smith Lemli Opitz Syndrome
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 17, 2022
Study of Smith-Lemli-Opitz Syndrome
Completed
- Smith-Lemli-Opitz Syndrome
- Cholesterol Suspension
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Smith-Lemli-Opitz Syndrome, Cone-Rod Dystrophy, Hearing Loss Trial in Aurora (Antioxidants, Cholesterol)
Recruiting
- Smith-Lemli-Opitz Syndrome
- +2 more
-
Aurora, ColoradoChildren's Hospital Colorado
Jan 4, 2022
Postoperative Atrial Fibrillation Trial (Discontinuance of treatment with statins 7 to 14 days prior to surgery until 30 days
Recruiting
- Postoperative Atrial Fibrillation
- Discontinuance of treatment with statins 7 to 14 days prior to surgery until 30 days postoperative
- No-intervention.
-
Odense, DenmarkOdense University Hospital
Sep 30, 2022
Carcinoma, Non-small Cell Lung Trial in Changsha (ethaselen)
Completed
- Carcinoma, Non-small Cell Lung
-
Changsha, Hunan, ChinaHunan province tumor hospital
Mar 1, 2022
Traumatic Brain Injury Trial (Simvastatin, Placebo drug)
Not yet recruiting
- Traumatic Brain Injury
- Simvastatin
- Placebo drug
- (no location specified)
Oct 6, 2022
C677T Methylenetetrahydrofolate Reductase Mutation
Completed
- Mutation
- infertily evaluation
- (no location specified)
May 16, 2023
Benign Prostatic Hyperplasia, Prostate Hyperplasia, Prostate Disease Trial in Boston (Finasteride)
Recruiting
- Benign Prostatic Hyperplasia
- +7 more
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Jan 26, 2022
(MTHFR C677T) in COVID-19patients
Completed
- COVID 19 Associated Coagulopathy
- RT- PCR of 2 ml EDTA blood sample to determine MTHFR C677T genotypes
-
Cairo, EgyptAin Shams University
Jan 9, 2023
Breast Cancer Female Trial (neoadjuvant chemo (AC-T protocol))
Not yet recruiting
- Breast Cancer Female
- neoadjuvant chemotherapy (AC-T protocol)
- (no location specified)
Aug 17, 2022
Diabetic Cardiomyopathies Trial in Worldwide (AT-001, Placebo)
Active, not recruiting
- Diabetic Cardiomyopathies
- AT-001
- Placebo
-
Beverly Hills, California
- +78 more
Dec 7, 2022
Acne Vulgaris, Vitamin D Trial in Jakarta Pusat (combination oral and topical vitamin D, oral and topical cholecalciferol, oral
Enrolling by invitation
- Acne Vulgaris
- Vitamin D
- combination oral and topical vitamin D
- +2 more
-
Jakarta Pusat, DKI Jakarta, IndonesiaRSUPN Dr. Cipto Mangunkusumo
Mar 4, 2023
Prostatic Tumors, Low Grade Prostate Cancer Trial in Quebec (Dietary intervention first, Drug (Dutasteride) intervention first)
Active, not recruiting
- Prostatic Neoplasms
- Low Grade Prostate Cancer
- Dietary intervention first
- Drug (Dutasteride) intervention first
-
Quebec, Canada
- +1 more
Mar 14, 2022
Neurodegenerative Disease, Hereditary, Mitochondrial Diseases, Optic Atrophy Trial in Buffalo (Mutation analysis)
Recruiting
- Neurodegenerative Disease, Hereditary
- +2 more
- Mutation analysis
-
Buffalo, New YorkUBMD Pediatrics
Mar 3, 2022
HIV Trial in Cincinnati (darunavir, ritonavir, rosuvastatin, rosuvastatin, darunavir, ritonavir)
Completed
- HIV Infections
- darunavir, ritonavir, rosuvastatin
- rosuvastatin, darunavir, ritonavir
-
Cincinnati, OhioUniversity of Cincinnati AIDS Clinical Trials Unit
Jan 19, 2022
Hypercholesterolemia Trial (Ezetimibe, atorvastatin)
Completed
- Hypercholesterolemia
- (no location specified)
Feb 7, 2022
Hypercholesterolemia Trial (Ezetimibe, Simvastatin)
Completed
- Hypercholesterolemia
- (no location specified)
Feb 7, 2022
Preventing Levodopa Induced Dyskinesia in Parkinson's Disease
Recruiting
- Parkinson Disease
- Dyskinesia, Drug-Induced
- Intravenous Infusion
-
Portland, Oregon
- +2 more
Dec 23, 2022
Pulpitis - Irreversible Trial in Ismailia (Biodentine, Simvastatin)
Completed
- Pulpitis - Irreversible
-
Ismailia, EgyptFaculty of dentistry, Suez canal university
Oct 12, 2022
Solid Tumor Trial in Duarte (RNR inhibitor COH29, laboratory biomarker analysis, pharmacological study)
Suspended
- Unspecified Adult Solid Tumor, Protocol Specific
- RNR inhibitor COH29
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Mar 17, 2022
Premature Birth Trial (Cervical cerclage, Vaginal Suppository Progesterone)
Not yet recruiting
- Premature Birth
- Cervical cerclage
- Vaginal Suppository Progesterone
- (no location specified)
Sep 11, 2023